2nd Quarter - Report

THE MCMANUS GROUP for AMGEN

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Access and reimbursement for Part B and Part D drugs. Provisions related to vial wastage rebates in Part B.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
ALANNA TEMME LD, Rep. Jon Porter

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.